TBXT and neoplasm: As the findings show, the tumor size of Xenograft mice immunized with NCIN87 cells treated with T-mab reduced obviously, while the tumor size of Xenograft mice immunized with NCIN87-DR cells treated with T-mab decreased less, showing obvious drug-resistance in vivo.